Imiquimod may potentiate melanoma vaccine effect


Newport Beach, Calif. — The immune response modifier imiquimod (Aldara, 3M Pharmaceuticals) may have a role as an enhancer of other immunotherapies for melanoma, Noah Craft, M.D., Ph.D. said here at the annual meeting of the Pacific Dermatologic Association (PDA).

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.